Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC NHS-modified MMAF (trifluoroacetate) | 96.0% | 1165.34 | C57H87F3N8O14 | 50 MG
Supplier: Medchemexpress LLC HY139325A50MG
NHS-modified MMAF (trifluoroacetate) is an NHS-activated derivative of monomethyl auristatin F provided as the trifluoroacetate salt. It is used as a synthetic intermediate for preparing antibody-drug conjugate payload-linker constructs via NHS-ester-mediated conjugation to amines on antibody binders.
- NHS-activated derivative for conjugation chemistry.
- Provided as the trifluoroacetate salt for stability.
- High purity suitable for research and ADC synthesis.
- Available in research-scale quantities for lab use.
- Documented with COA and SDS for quality and safety information.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?